Rather than using M&A to focus on expansion and diversification into new value pools, many US healthcare players are deploying it to access new capabilities and enhance existing assets.The industry overviewDealmaking in US healthcare remained stable in 2025 relative to the sector’s M&A activity in 2023 and 2024 (Exhibit 1). According to our analysis, dealmakers […]

Author